Susan Shanley

6.4k citations

34 papers · 2.4k indexed · 1 hit paper · h-index 18

Co-authors: Rosalind A. Eeles Georgia Chenevix‐Trench Carol Wicking Andrew Tutt Roger A’Hern Audrey Ardern‐Jones Jan Lubiński Jacques De Grève
Topics: BRCA gene mutations in cancer (15 papers)Hedgehog Signaling Pathway Studies (9 papers)Genetic factors in colorectal cancer (7 papers)
Cited by: Reproductive Medicine Oncology Genetics
Journals: Journal of Clinical Oncology Clinical Cancer Research Human Molecular Genetics
Partner nations: United Kingdom Australia United States

In The Last Decade

Susan Shanley

34 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval

2010 745 citations Peter C.C. Fong, Timothy A. Yap et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Susan Shanley

Since Specialization

Citations

This map shows the geographic impact of Susan Shanley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Shanley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Shanley more than expected).

Fields of papers citing papers by Susan Shanley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Shanley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Shanley. The network helps show where Susan Shanley may publish in the future.

Co-authorship network of co-authors of Susan Shanley

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Shanley. A scholar is included among the top collaborators of Susan Shanley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Shanley. Susan Shanley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Current mismatch repair deficiency tumor testing practices and capabilities: A survey of Australian pathology providers 2018 ·Asia-Pacific Journal of Clinical Oncology ·Lyon Mascarenhas,Susan Shanley,Gillian Mitchell,Amanda B. Spurdle,Finlay Macrae,Nicholas Pachter,Daniel D. Buchanan,Robyn L. Ward,Stephen B. Fox,(unknown),Rebecca Driessen,Alex Boussioutas	9
2	Diagnosis and Management of Hereditary Basal Cell Skin Cancer 2016 ·Recent results in cancer research ·Susan Shanley,Christopher McCormack	3
3	BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years 2012 ·British Journal of Cancer ·(unknown),Lindsay B. Robertson,Helen Hanson,S. Seal,Margaret Warren-Perry,Deborah Hughes,Imran Howell,Clare Turnbull,Richard S. Houlston,Susan Shanley,Stephen A. Butler,D. Gareth Evans,Gill Ross,Diana Eccles,Andrew Tutt,Nazneen Rahman	79
4	Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening tests 2011 ·Hereditary Cancer in Clinical Practice ·Marielle Nobbenhuis,Elizabeth Bancroft,Eleanor Moskovic,(unknown),Paul D.P. Pharoah,Ian Jacobs,Ann Ward,(unknown),Thomas Ind,John H. Shepherd,Jane Bridges,Martin Gore,(unknown),Susan Shanley,Audrey Ardern‐Jones,Sarah Thomas,Rosalind A. Eeles	5
5	Implications for cancer genetics practice of pro-actively assessing family history in a General Practice cohort in North West London 2011 ·Familial Cancer ·Kelly Kohut,(unknown),Elizabeth Bancroft,Sarah Thomas,Mary‐Anne Young,Kathryn Myhill,Susan Shanley,(unknown),Michelle G. Newman,(unknown),(unknown),(unknown),(unknown),(unknown),Rosalind A. Eeles,(unknown)	7
6	Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Intervalbreakdown → 2010 ·Journal of Clinical Oncology ·Peter C.C. Fong,Timothy A. Yap,David S. Boss,Craig P. Carden,Marja Mergui‐Roelvink,Charlie Gourley,Jacques De Grève,Jan Lubiński,Susan Shanley,Christina Messiou,Roger A’Hern,Andrew Tutt,Alan Ashworth,John Stone,James Carmichael,Jan H.M. Schellens,Johann S. de Bono,Stan B. Kaye	745
7	The carrier clinic: an evaluation of a novel clinic dedicated to the follow-up of BRCA1 and BRCA2 carriers—implications for oncogenetics practice 2010 ·Journal of Medical Genetics ·Elizabeth Bancroft,Imogen Locke,Audrey Ardern‐Jones,(unknown),(unknown),(unknown),Yolanda Barbáchano,Julian Barwell,Lyndon Walker,Geraldine M. Mitchell,Huw Dorkins,(unknown),J. Paterson,(unknown),Anita Mitra,Sameer Jhavar,(unknown),Richard S. Houlston,Susan Shanley,Rosalind A. Eeles	11
8	BRCA1andBRCA2heterozygosity in embryonic stem cells reduces radiation-induced Rad51 focus formation but is not associated with radiosensitivity 2010 ·International Journal of Radiation Biology ·(unknown),M. Ismail,Lisa Föhse,Susan Shanley,(unknown),Susan Short	6
9	Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis 2010 ·Clinical Genetics ·(unknown),Arjen R. Mensenkamp,Sadhanna Badeloe,(unknown),(unknown),(unknown),(unknown),(unknown),Susan Shanley,(unknown),L. H. Hoefsloot,(unknown),(unknown),(unknown),Josef Frank,Maurice A. M. Van Steensel,(unknown)	127
10	Unusual presentation of Lynch Syndrome 2009 ·Hereditary Cancer in Clinical Practice ·Veronica Yu,Marco Novelli,Stewart J. Payne,(unknown),Rebecca A. Barnetson,Ian M. Frayling,Ann Barrett,David Goudie,Audrey Ardern‐Jones,Rosalind A. Eeles,Susan Shanley	13
11	Breast cancer immunohistochemistry can be useful in triage of some HNPCC families 2009 ·Familial Cancer ·Susan Shanley,(unknown),J. Milliken,James F. Leary,Rebecca A. Barnetson,Mark A. Schnitzler,Judy Kirk	19
12	Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics 2008 ·Journal of Medical Genetics ·Antonis C. Antoniou,Rachel Hardy,Lyndon Walker,D. Gareth Evans,A Shenton,Rosalind A. Eeles,Susan Shanley,Gabriella Pichert,Louise Izatt,Stephen Rose,Gillian Douglas,Diana Eccles,Patrick J. Morrison,(unknown),Ron Zimmern,Douglas F. Easton,Paul D.P. Pharoah	137
13	Genetic testing for BRCA1: effects of a randomised study of knowledge provision on interest in testing and long term test uptake; implications for the NICE guidelines 2008 ·Familial Cancer ·(unknown),Susan W. Gray,Roger A’Hern,Susan Shanley,Maggie Watson,Kathryn M. Kash,Robert T. Croyle,Rosalind A. Eeles	9
14	Delivery of cancer genetics services: The Royal Marsden telephone clinic model 2007 ·Familial Cancer ·Susan Shanley,Kathryn Myhill,Rebecca Doherty,Audrey Ardern‐Jones,(unknown),(unknown),Sarah Thomas,Peter J. Aspinall,Rosalind A. Eeles	8
15	Accurate Prediction of BRCA1 and BRCA2 Heterozygous Genotype Using Expression Profiling after Induced DNA Damage 2006 ·Clinical Cancer Research ·Zsofia Kote‐Jarai,Lucy Matthews,Ana Osório,Susan Shanley,Ian Giddings,François Moreews,Imogen Locke,D. Gareth Evans,Diana Eccles,Richard D. Williams,Mark Girolami,Colin Campbell,Rosalind A. Eeles	29
16	Increased level of chromosomal damage after irradiation of lymphocytes from BRCA1 mutation carriers 2005 ·British Journal of Cancer ·Zsofia Kote‐Jarai,Asher Salmon,(unknown),Michelle Copeland,Audrey Ardern‐Jones,Imogen Locke,Susan Shanley,Brenda Summersgill,Yong‐Jie Lu,Janet Shipley,Rosalind A. Eeles	28
17	The spectrum ofpatched mutations in a collection of Australian basal cell carcinomas 2000 ·Human Mutation ·Timothy Evans,Waranya Boonchai,Susan Shanley,Ian Smyth,Susan A Gillies,Kylie Georgas,Brandon J. Wainwright,Georgia Chenevix‐Trench,Carol Wicking	20
18	Glutathione S-transferase GSTM1 null genotype is not overrepresented in Australian patients with nevoid basal cell carcinoma syndrome or sporadic melanoma 1995 ·Carcinogenesis ·Susan Shanley,(unknown),Jane M. Palmer,Nicholas K. Hayward	22
19	Nevoid basal cell carcinoma syndrome: Review of 118 affected individuals 1994 ·American Journal of Medical Genetics ·Susan Shanley,John W. Ratcliffe,Athel Hockey,Eric Haan,Christine Oley,David Ravine,Nicholas G. Martin,Carol Wicking,Georgia Chenevix‐Trench	250
20	Excessive Follicular Recruitment and Growth in Mothers of Spontaneous Dizygotic Twins 1991 ·Acta geneticae medicae et gemellologiae twin research ·Nicholas G. Martin,Susan Shanley,(unknown),John R. Osborne,(unknown)	37

About Susan Shanley

Susan Shanley is a scholar working on Genetics, Dermatology and Cancer Research, having authored 34 papers that have together received 2.4k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (15 papers), Hedgehog Signaling Pathway Studies (9 papers) and Genetic factors in colorectal cancer (7 papers). The work is most often cited by research in Reproductive Medicine (561 citations), Oncology (1.1k citations) and Genetics (967 citations). Susan Shanley has collaborated with scholars based in United Kingdom, Australia and United States. Frequent co-authors include Rosalind A. Eeles, Georgia Chenevix‐Trench, Carol Wicking, Andrew Tutt, Roger A’Hern, Audrey Ardern‐Jones, Jan Lubiński, Jacques De Grève, Alan Ashworth and Charlie Gourley. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and Human Molecular Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact